Loading
Latest filing published 07 Jan 2025 for Brainstorm Cell Therapeutics INC..
No signal scores available.
Ibrahim B. Dagher discloses dealings in Brainstorm Cell Therapeutics Inc. to SEC (Form 4). The record holds 2 filings, for trades running from 19 July 2024 to 1 January 2025.
Sales make up the whole of the open-market record (1 sale, €20k). The rest of the record consists of 1 share grant.
The latest filing, published on 7 January 2025, reports a share grant in Brainstorm Cell Therapeutics Inc. Keep in mind that insiders sell for many reasons unrelated to the outlook, from tax bills to estate planning. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
2 of 2 declarations